CoreCivic IncCEO Patrick Swindle resigned for cancer treatment and was replaced internally, an unplanned leadership exit that sent shares down 4.3%.

CoreCivic said president, chief executive officer, and director Patrick D. Swindle resigned to pursue treatment for stage four metastatic pancreatic cancer, and the board appointed Lucibeth N. Mayberry to the same three roles, sending shares down 4.3% in the afternoon session. Swindle, who had been chief executive since January 1, 2026, said in the company's press release that he was stepping down to pursue that treatment, and board chair Mark Emkes said he will remain a special adviser through the transition. Mayberry has worked at CoreCivic since May 2003 and had been executive vice president and chief strategy officer since May 2025; she said she will continue the current capital-allocation strategy. The successor is internal and the strategy she named is the one already in place, so Friday's decline prices an unplanned exit by a chief executive who took the job at the start of the year. CoreCivic shares are up 71% since the beginning of the year and, at $32.53 per share, are trading close to their 52-week high of $35.54 from September 2026.
CoreCivic IncCEO Patrick Swindle resigned for cancer treatment and was replaced internally, an unplanned leadership exit that sent shares down 4.3%.